PRME
Income statement / Annual
Last year (2024), Prime Medicine, Inc.'s total revenue was $2.98 M,
and the percentage change from the previous year is not available.
In 2024, Prime Medicine, Inc.'s net income was -$195.88 M.
See Prime Medicine, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.98 M |
$0.00 |
$0.00 |
$0.00 |
$5.21 M |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.98 M
|
$2.76 M
|
| Gross Profit |
$2.98 M
|
$0.00
|
$0.00
|
$0.00
|
$2.23 M
|
-$2.76 M
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
0.43
|
0
|
| Research and Development Expenses |
$155.29 M
|
$147.91 M
|
$86.73 M
|
$70.55 M
|
$2.98 M
|
$920.00 K
|
| General & Administrative Expenses |
$50.16 M
|
$43.39 M
|
$29.82 M
|
$13.92 M
|
$3.16 M
|
$3.76 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.25 M
|
| Selling, General & Administrative Expenses |
$50.16 M
|
$43.39 M
|
$29.82 M
|
$13.92 M
|
$3.16 M
|
$1.25 M
|
| Other Expenses |
$0.00
|
$13.50 M
|
$0.00
|
$0.00
|
-$2.98 M
|
$0.00
|
| Operating Expenses |
$205.45 M
|
$204.79 M
|
$116.54 M
|
$84.47 M
|
$3.16 M
|
$2.17 M
|
| Cost And Expenses |
$205.45 M
|
$204.79 M
|
$116.54 M
|
$84.47 M
|
$6.14 M
|
$2.17 M
|
| Interest Income |
$3.52 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$6.13 M
|
$4.65 M
|
$2.22 M
|
$568.00 K
|
$43.00 K
|
$6.52 M
|
| EBITDA |
-$196.34 M |
-$186.64 M |
-$114.32 M |
-$83.91 M |
-$889.00 K |
-$2.17 M |
| EBITDA Ratio |
-65.82
|
0
|
0
|
0
|
-0.17
|
0
|
| Operating Income Ratio |
-67.87
|
0
|
0
|
0
|
-0.18
|
0
|
| Total Other Income/Expenses Net |
$6.59 M
|
$6.38 M
|
-$6.23 M
|
-$81.38 M
|
-$611.00 K
|
$0.00
|
| Income Before Tax |
-$195.88 M
|
-$198.41 M
|
-$122.77 M
|
-$165.85 M
|
-$1.54 M
|
-$2.53 M
|
| Income Before Tax Ratio |
-65.67
|
0
|
0
|
0
|
-0.3
|
0
|
| Income Tax Expense |
$0.00
|
-$279.00 K
|
-$948.00 K
|
-$486.00 K
|
$1.87 M
|
$4.00 K
|
| Net Income |
-$195.88 M
|
-$198.13 M
|
-$121.82 M
|
-$165.37 M
|
-$3.41 M
|
-$2.53 M
|
| Net Income Ratio |
-65.67
|
0
|
0
|
0
|
-0.65
|
0
|
| EPS |
-1.6516 |
-2.178 |
-1.4609 |
-1.9233 |
-0.0528 |
-0.0292 |
| EPS Diluted |
-1.6516 |
-2.178 |
-1.4609 |
-1.9233 |
-0.0528 |
-0.0292 |
| Weighted Average Shares Out |
$118.60 M
|
$90.97 M
|
$97.21 M
|
$95.73 M
|
$95.73 M
|
$95.73 M
|
| Weighted Average Shares Out Diluted |
$118.60 M
|
$90.97 M
|
$97.21 M
|
$95.73 M
|
$95.73 M
|
$95.73 M
|
| Link |
|
|
|
|
|
|
